January 22, 2009 - Paramedic Service Awards Preferred Defibrillator Vendor Status INVESTOR CONTACT: A. Ernest WhitonChief Financial OfficerZOLL Medical Corporation+1 (978) 421-9655 MEDIA CONTACT: Diane EganZOLL Medical Corporation+1 (978) email@example.com OTTAWA PARAMEDIC SERVICE AWARDS ZOLL A THIRD CONTRACT AS PREFERRED VENDOR FOR DEFIBRILLATORS January 22, 2009—CHELMSFORD, Mass.—ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced today that Ottawa Paramedic Service (OPS), which provides emergency medical services to the Canadian capital city of Ottawa, Ontario, has awarded ZOLL over a $2 million contract to supply defibrillators for its municipal and public access programs. Under the terms of the agreement, OPS will purchase 113 E Series® defibrillators, 440 AED Plus® units, and 84 AED Pro® models from ZOLL for use on the city’s EMS, fire and police service vehicles and various community centers. The agreement marks the third major purchase of ZOLL advanced and basic life support equipment by OPS since the service was created in 2001 as one of the largest pre-hospital providers in Canada. “All of ZOLL’s equipment use the same operating system, work similarly, and are easy to use. We were looking at a fully integrated system as the most significant factor in providing care to our community,” said Chief Anthony Di Monte. “With the astounding success of our STEMI program, our service is one of the most sophisticated pre-hospital services in North America, and ZOLL’s system will allow us to continue the highest level of care possible to the 880,000 citizens and the 7 million annual visitors to Canada’s capital,” adds Chief Di Monte. “ZOLL is extremely pleased that Ottawa Paramedic Service places such a high value on our resuscitation equipment in helping to improve survival rates from sudden cardiac arrest, the leading cause of unexpected death worldwide,” said Richard A. Packer, Chairman and Chief Executive Officer of ZOLL. The ZOLL E Series is designed to meet the specific demands and extreme conditions that professional rescuers face every day. The E Series offers multiple data transmission options to a variety of destinations, including transmission of 12-lead ECGs to hospitals, which International Guidelines now recommend for out-of-hospital use to help reduce time to perfusion in S-T segment elevation myocardial infarction (STEMI) patients. Real CPR Help® in all of ZOLL’s devices instantly provides first responders and advanced paramedics with technology to see how well they are performing the rate and depth of CPR chest compressions. See-Thru CPR®, on the E Series and AED Pro advanced devices, can help them minimize interruptions in CPR that effect resuscitation success. About Sudden Cardiac Arrest SCA claims more than 1 million lives each year worldwide. It is the leading cause of unexpected death in the world and strikes without warning. Currently, only about 5 percent of victims survive; 95 percent will die from SCA. SCA is an abrupt disruption of the heart’s function, which causes a lack of blood flow to vital organs. CPR and a defibrillating shock are essential to helping restore the heart’s normal rhythm and circulation. About Ottawa Paramedic Service Ottawa Paramedic Service delivers sophisticated medical treatment to all residents and visitors of Ottawa for life-threatening emergencies. In 2008, Ottawa paramedics responded to nearly 100,000 medical emergencies. All 342 of Ottawa’s highly-trained paramedics form an integral part of the city’s emergency preparedness team and are the sole medically certified providers of out-of-the-hospital medical treatment. About ZOLL Medical Corporation ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies, including Real CPR Help® and See-Thru CPR®, that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information. ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia. 2008 marks the 25th anniversary of ZOLL’s resuscitation product development. For more information, visit www.zoll.com. Certain statements contained in this press release, including statements regarding the future business of the Company, and other statements contained herein regarding matters that are not historical facts, are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled “Risk Factors” in the Company's Annual Report on Form 10-K filed with the SEC on December 8, 2008. You should not place undue reliance on the forward-looking statements in this press release, and the Company disavows any obligation to update or supplement those statements in the event of any changes in the facts, circumstances, or expectations that underlie those statements. Copyright © 2009 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. ZOLL, AED Plus, AED Pro, E Series, Real CPR Help, and See-Thru CPR are registered trademarks of ZOLL Medical Corporation.